Are there health concerns with low VLDL?

While low VLDL cholesterol is generally considered healthy and protective against heart disease, extremely low levels below 2 mg/dL may indicate underlying health issues like malnutrition, hyperthyroidism, or liver problems. Most people with low VLDL don't need treatment unless accompanied by other symptoms.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding VLDL cholesterol and its role in your body

Very low-density lipoprotein (VLDL) cholesterol is one of the five major types of lipoproteins that transport fats and cholesterol throughout your bloodstream. Produced by your liver, VLDL particles primarily carry triglycerides to your tissues for energy or storage. As VLDL particles release their triglyceride cargo, they transform into intermediate-density lipoproteins (IDL) and eventually into low-density lipoproteins (LDL), often called 'bad cholesterol.'

Unlike HDL cholesterol, which helps remove excess cholesterol from your arteries, VLDL contributes to plaque buildup in arterial walls. This makes it a significant player in cardiovascular disease risk. Normal VLDL levels typically range from 2 to 30 mg/dL, though some labs may use slightly different reference ranges. While high VLDL levels are clearly linked to increased heart disease risk, the implications of low VLDL are more nuanced and less straightforward.

When low VLDL is actually a good sign

In most cases, having low VLDL cholesterol is beneficial for your cardiovascular health. Lower VLDL levels mean less triglyceride-rich particles circulating in your blood, reducing the potential for arterial plaque formation. People who maintain healthy lifestyles often naturally have lower VLDL levels, which correlates with reduced risk of heart disease, stroke, and other cardiovascular events.

VLDL Level Categories and Clinical Significance

VLDL Level (mg/dL)CategoryHealth ImplicationsRecommended Action
Below 2<2 mg/dLExtremely LowMay indicate malnutrition, malabsorption, or underlying conditionEvaluate for symptoms; consider further testing
2-52-5 mg/dLVery LowUsually benign; may be genetic or lifestyle-relatedNo action needed if asymptomatic
5-305-30 mg/dLNormal/OptimalHealthy range; protective against cardiovascular diseaseMaintain healthy lifestyle
Above 30>30 mg/dLHighIncreased cardiovascular riskLifestyle modifications; consider medical evaluation

VLDL levels should be interpreted alongside complete lipid panel results and clinical symptoms.

Several positive lifestyle factors can lead to lower VLDL levels:

  • Regular aerobic exercise, which improves lipid metabolism
  • A diet low in saturated fats and refined carbohydrates
  • Maintaining a healthy body weight
  • Limiting alcohol consumption
  • Not smoking

If your VLDL levels are low due to these healthy habits, it's generally a positive indicator of good metabolic health. Many people with VLDL levels between 5-15 mg/dL have excellent cardiovascular profiles and no associated health concerns. Regular monitoring of your complete lipid panel can help ensure your cardiovascular health stays on track.

Potential concerns with extremely low VLDL

While low VLDL is typically beneficial, extremely low levels (below 2 mg/dL) may occasionally signal underlying health issues. The concern isn't usually the low VLDL itself, but rather what might be causing such unusually low levels. Understanding these potential causes can help you and your healthcare provider determine if further investigation is needed.

Malnutrition and malabsorption

Severe malnutrition or malabsorption disorders can lead to extremely low VLDL levels. When your body doesn't receive adequate nutrients, particularly fats and proteins, your liver may not have the raw materials needed to produce VLDL particles. Conditions like celiac disease, Crohn's disease, or severe eating disorders can impair nutrient absorption and lead to abnormally low lipid levels across the board.

Hyperthyroidism

An overactive thyroid gland can significantly impact lipid metabolism. Hyperthyroidism accelerates your body's metabolic rate, which can lead to rapid breakdown of fats and cholesterol. This increased metabolism often results in lower levels of all cholesterol types, including VLDL. If you have unexplained low VLDL along with symptoms like weight loss, rapid heartbeat, anxiety, or heat intolerance, thyroid function testing may be warranted.

Liver dysfunction

Since the liver produces VLDL, significant liver disease can impair this production. Conditions like cirrhosis, hepatitis, or severe fatty liver disease may result in decreased VLDL synthesis. However, liver problems typically cause multiple abnormal lab values, not just isolated low VLDL. Your healthcare provider would likely notice elevated liver enzymes or other concerning markers if liver disease were present.

Genetic factors affecting VLDL levels

Some people have genetically low VLDL levels due to inherited conditions affecting lipid metabolism. Familial hypobetalipoproteinemia and abetalipoproteinemia are rare genetic disorders that cause extremely low levels of apolipoprotein B-containing lipoproteins, including VLDL. These conditions can lead to fat malabsorption, vitamin deficiencies (particularly fat-soluble vitamins A, D, E, and K), and neurological problems if left untreated.

More commonly, genetic variations can cause moderately low VLDL levels without any health consequences. If you have a family history of naturally low cholesterol levels and no associated symptoms, your low VLDL may simply be a benign genetic trait. Understanding your complete lipid profile and family history can help distinguish between beneficial genetic variations and those requiring medical attention.

Symptoms associated with problematic low VLDL

Low VLDL itself rarely causes symptoms. However, if your low VLDL is due to an underlying condition, you might experience symptoms related to that condition. Being aware of these potential warning signs can help you determine when to seek medical evaluation:

  • Unexplained weight loss or difficulty maintaining weight
  • Chronic diarrhea or fatty stools (steatorrhea)
  • Fatigue or weakness
  • Night blindness or other vision problems
  • Neurological symptoms like numbness, tingling, or coordination problems
  • Easy bruising or bleeding
  • Muscle cramps or weakness

If you experience any of these symptoms along with low VLDL levels, it's important to discuss them with your healthcare provider. They can help determine whether your low VLDL is a benign finding or if it warrants further investigation.

Testing and monitoring your VLDL levels

VLDL cholesterol is typically calculated rather than directly measured. Most labs estimate VLDL by dividing your triglyceride level by 5 (when triglycerides are below 400 mg/dL). This calculation assumes a standard ratio of triglycerides to VLDL, though individual variations exist. For the most accurate assessment of your cardiovascular risk, it's important to look at your complete lipid panel, including total cholesterol, LDL, HDL, and triglycerides.

Advanced lipid testing can provide more detailed information about your cholesterol particles. Tests measuring apolipoprotein B (ApoB) levels or particle numbers can offer insights beyond standard cholesterol measurements. ApoB represents the total number of atherogenic particles in your blood, including VLDL, IDL, and LDL, providing a comprehensive view of your cardiovascular risk. Regular monitoring through comprehensive testing programs can help you track these important markers over time.

Managing and optimizing your VLDL levels

If your VLDL levels are low but within a healthy range (5-30 mg/dL), no specific treatment is needed. Continue maintaining the healthy habits that contribute to optimal lipid levels. However, if your VLDL is extremely low and accompanied by concerning symptoms, addressing the underlying cause is key.

For those with malabsorption issues, working with a gastroenterologist and registered dietitian can help improve nutrient absorption. This might involve treating underlying conditions like celiac disease or adjusting your diet to include more easily absorbed nutrients. In cases of hyperthyroidism, treating the thyroid condition typically normalizes lipid levels. Liver disease requires specialized care to address the underlying liver dysfunction.

If genetic factors cause your low VLDL, management depends on the specific condition. Some genetic disorders causing low VLDL require supplementation with fat-soluble vitamins and dietary modifications. Working with a lipid specialist can help develop an appropriate management plan tailored to your specific needs.

The bottom line on low VLDL cholesterol

For most people, low VLDL cholesterol is a positive health indicator associated with reduced cardiovascular disease risk. It often reflects healthy lifestyle choices like good nutrition, regular exercise, and maintaining a healthy weight. However, extremely low levels, especially when accompanied by other symptoms or abnormal lab values, may warrant further investigation to rule out underlying health conditions.

The key is understanding your complete health picture, not just focusing on a single lab value. Regular monitoring of your lipid panel, along with attention to any unusual symptoms, can help you and your healthcare provider determine whether your low VLDL levels are beneficial or require further evaluation. Remember that optimal health involves balancing multiple factors, and what's normal for one person may differ from another based on genetics, lifestyle, and overall health status.

References

  1. Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37(25):1944-1958.[PubMed][DOI]
  2. Schaefer EJ, Gregg RE, Ghiselli G, et al. Familial apolipoprotein E deficiency. J Clin Invest. 1986;78(5):1206-1219.[PubMed][DOI]
  3. Burnett JR, Hooper AJ. Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia. Free Radic Biol Med. 2015;88(Pt A):59-62.[PubMed][DOI]
  4. Duntas LH, Brenta G. The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am. 2012;96(2):269-281.[PubMed][DOI]
  5. Welty FK. Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease. Curr Opin Lipidol. 2020;31(2):49-55.[PubMed][DOI]
  6. Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol. 2019;4(12):1287-1295.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my VLDL at home?

You can test your VLDL at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes VLDL testing as part of a comprehensive cardiovascular panel, providing lab-quality results from the comfort of your home.

What is considered a dangerously low VLDL level?

VLDL levels below 2 mg/dL are considered extremely low and may warrant further investigation, especially if accompanied by symptoms like unexplained weight loss, fatigue, or digestive issues. However, levels between 5-30 mg/dL are generally healthy and protective against heart disease.

Can medications cause low VLDL cholesterol?

Yes, certain medications can lower VLDL levels, including statins, fibrates, and niacin. These medications are typically prescribed to reduce cardiovascular risk, and the resulting low VLDL is usually beneficial. Thyroid medications for hypothyroidism may also affect VLDL levels.

Should I try to raise my VLDL if it's low?

In most cases, you should not try to raise low VLDL levels, as they're generally protective against heart disease. Only if your levels are extremely low (below 2 mg/dL) and you have symptoms or other health concerns should you work with a healthcare provider to address potential underlying causes.

How often should I check my VLDL levels?

For most adults, checking VLDL as part of a complete lipid panel every 3-6 months is sufficient if you're actively monitoring your cardiovascular health. Those with risk factors or on lipid-lowering medications may benefit from more frequent testing to track their progress.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details